Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06039566 · ClinicalTrials.gov registry record · Phase 3
NAC vs Placebo on Opioid Use for Hysterectomy
A Phase 3 study of Hysterectomy, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06039566 is a Phase 3 study of Hysterectomy that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 240 participants, above the 110-participant average among 8 other Hysterectomy trials with a reported enrollment target (118% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06039566, a Phase 3 study of Hysterectomy, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll females who are ages 18 and older undergoing a laparoscopic or robotic, partial or full hysterectomy. Participants will be randomized to receive IV n-acetylcysteine or placebo during the first 60 minutes of their procedure. At various time points after the procedure patients will be asked to report their pain scores, and any pain medication taken.
Conditions Studied
Interventions
- DRUG IV N-acetylcysteine
- DRUG IV Placebo
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2026-12-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06039566
The ClinicalTrials.gov registry entry for NCT06039566 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 8 other Hysterectomy trials with a reported enrollment target (118% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hysterectomy appearing as the primary indexed condition, and to 2 interventions - of which IV N-acetylcysteine is the first listed.
NCT06039566 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06039566 about?
NCT06039566 is a clinical study titled "NAC vs Placebo on Opioid Use for Hysterectomy". This study will enroll females who are ages 18 and older undergoing a laparoscopic or robotic, partial or full hysterectomy. Participants will be randomized to receive IV n-acetylcysteine or placebo during the first 60 minutes of their procedure. At various time points after the procedure patients w...
What is the current status of trial NCT06039566?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2023-11-30. Estimated completion is 2026-12-09.
What conditions does trial NCT06039566 study?
This clinical trial studies the following conditions: Hysterectomy.
What interventions are being tested in trial NCT06039566?
The interventions under investigation include: IV N-acetylcysteine (DRUG), IV Placebo (DRUG).
Who is sponsoring clinical trial NCT06039566?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06039566 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
COMPLETED · Phase 3
-
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
RECRUITING · Phase 4
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
COMPLETED · Phase 4
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.